NDC 17856-0949

Megace ES

Megesterol Acetate

Megace ES is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Atlantic Biologicals Corps. The primary component is Megestrol Acetate.

• Product ID: 17856-0949_bcb4eb8f-40da-47b5-9061-dbc973467acb
• NDC: 17856-0949
• Product Type: Human Prescription Drug
• Proprietary Name: Megace ES
• Generic Name: Megesterol Acetate
• Dosage Form: Suspension
• Route of Administration: ORAL
• Marketing Start Date: 2005-07-02
• Marketing Category: NDA / NDA
• Application Number: NDA021778
• Labeler Name: Atlantic Biologicals Corps
• Substance Name: MEGESTROL ACETATE
• Active Ingredient Strength: 125 mg/mL
• Pharm Classes: Progesterone Congeners [CS],Progestin [EPC]
• NDC Exclude Flag: E
• Listing Certified Through: 2018-12-31

Packaging

NDC 17856-0949-5

5 mL in 1 CUP (17856-0949-5)

• Marketing Start Date: 2005-07-02
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 17856-0949-5 [17856094905]

Megace ES SUSPENSION

• Marketing Category: NDA
• Application Number: NDA021778
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2005-07-02
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
MEGESTROL ACETATE	125 mg/mL

OpenFDA Data

• SPL SET ID: 654854bc-f847-4e3b-a0a1-8716553460ac
• Manufacturer:
  • Atlantic Biologicals Corps
• UNII:
  • TJ2M0FR8ES
• RxNorm Concept Unique ID - RxCUI:
  • 577154
  • 885111

Pharmacological Class

• Progesterone Congeners [CS]
• Progestin [EPC]

NDC Crossover Matching brand name "Megace ES" or generic name "Megesterol Acetate"

NDC	Brand Name	Generic Name
17856-0949	Megace ES	megesterol acetate
49884-949	Megace ES	megesterol acetate
63481-160	Megace ES	megesterol acetate